The Drug Development Cluster (Europe) offers an integrated set of drug development services to support small molecule preclinical R&D, all delivered in seamless fashion from a group of industry-leading contract research organizations. From discovery services to IND/IMPD, the cluster members have an excellent track record in pharmaceutical development throughout the last 10-15 years. This combination of four leading companies is available as a single team to lead your project toward proof of concept – fast and cost effectively. Drug Development Cluster members include:

Cambridge Major Laboratories – API Development

Cambridge Major Laboratories (CML) is a leading global chemistry outsourcing partner to the pharmaceutical and biotechnology industries. Cambridge Major produces pharmaceutical intermediates and Active Pharmaceutical Ingredients (API), from early preclinical development to commercial manufacture. Operating from FDA inspected facilities in the U.S. and Europe, Cambridge Major is organized along five key Centers of Excellence including Process Chemistry, GMP Manufacturing, Solid State Chemistry, Analytical Sciences, and Quality/Regulatory Compliance.

Mercachem – Medicinal Chemistry

Mercachem is a privately owned leading European contract research organization offering innovative chemistry, medicinal chemistry and process R&D services to accelerate the drug discovery and development process in a flexible and cost-effective way. Mercachem was founded in 1997, occupies state-of-the-art research facilities in Nijmegen and employs more than 100 chemists. Working for many pharmaceutical and biotech companies throughout the world, Mercachem is recognized for high-quality products and services and its unprecedented problem solving capabilities.

WIL Research – Preclinical Toxicology

WIL Reserach specializes in personalized contract research and expert consultancy for the registration of pharmaceutical products and (agro)chemicals worldwide. More than 300 well-trained and dedicated specialists operate modern purpose built laboratories and offices to perform regulatory toxicology studies. Its operations have been endorsed by the GLP Monitoring authorities (OECD/EPA/FDA/JMAFF certification).
SEPS Pharma – Preformulation/Formulation Development

SEPS Pharma offers a full suite of drug development services encompassing preclinical development, preformulation development, formulation development, dosage forms development and scaling-up of small molecules and biopharmaceuticals for oral, pulmonary, nasal and parenteral delivery.